Evidence map›Paper›PMID 31536526›Full record

ArticlePloS one2019

Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients.

Rachel B Ger, Shouhao Zhou, Baher Elgohari, Hesham Elhalawani, Dennis M Mackin, Joseph G Meier, Callistus M Nguyen, Brian M Anderson, Casey Gay, Jing Ning and 8 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. External validation of anEuropean journal of nuclear medicine and molecular imaging · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Rachel B GerDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.ORCID 0000-0003-1244-7160
Shouhao ZhouMD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.ORCID 0000-0002-8124-5047
Baher ElgohariDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Hesham ElhalawaniDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Dennis M MackinDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.ORCID 0000-0002-2557-5340
Joseph G MeierMD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Callistus M NguyenDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Brian M AndersonMD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Casey GayDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Jing NingDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Clifton D FullerMD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Heng LiDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Rebecca M HowellDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Rick R LaymanMD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Osama MawlawiMD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
R Jason StaffordMD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America.
Hugo AertsDepartment of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Laurence E CourtDepartment of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Convalescent Plasma to Limit Coronavirus Associated ComplicationsUL1TR003167 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARP, DANIEL D, MCPHERSON, DAVID D · 2019 to 2023
$45.3M
Targeting the p53 pathway for reversal of oral premalignancyP50CA097007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MYERS, JEFFREY NICHOLAS · 2002 to 2012
$26.1M
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR01DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2016 to 2020
$2.9M
SMART-ACT: Spatial Methodologic Approaches for Risk Assessment and Therapeutic Adaptation in Cancer TreatmentR01CA214825 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CANAHUATE, GUADALUPE, FULLER, CLIFTON DAVID · 2017 to 2019
$1.1M
imaging Radiation-Associated Dysphagia (iRAD)R01CA218148 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FULLER, CLIFTON DAVID, HUTCHESON, KATHERINE ARNOLD · 2017 to 2019
$810k
Fellow and Resident Radiation Oncology iNtensive Training in Imaging and Informatics to Empower Research Careers (FRONTI2ER)R25EB025787 · NIBIB · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DAS, PRAJNAN, FULLER, CLIFTON DAVID · 2018 to 2022
$535k
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular OsteoradionecrosisR56DE025248 · NIDCR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LAI, STEPHEN Y · 2015 to 2015
$470k
Understanding Uncertainties in Radiomics StudiesR21CA216572 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI COURT, LAURENCE E · 2017 to 2018
$313k
NCATS NIH HHS UL1 TR003167NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA097007NCI NIH HHS R01 CA214825NCI NIH HHS R01 CA218148NCI NIH HHS R21 CA216572NIBIB NIH HHS R25 EB025787NIDCR NIH HHS R01 DE025248NIDCR NIH HHS R56 DE025248
6 · The paper itself

Abstract

Radiomics studies require many patients in order to power them, thus patients are often combined from different institutions and using different imaging protocols. Various studies have shown that imaging protocols affect radiomics feature values. We examined whether using data from cohorts with controlled imaging protocols improved patient outcome models. We retrospectively reviewed 726 CT and 686 PET images from head and neck cancer patients, who were divided into training or independent testing cohorts. For each patient, radiomics features with different preprocessing were calculated and two clinical variables-HPV status and tumor volume-were also included. A Cox proportional hazards model was built on the training data by using bootstrapped Lasso regression to predict overall survival. The effect of controlled imaging protocols on model performance was evaluated by subsetting the original training and independent testing cohorts to include only patients whose images were obtained using the same imaging protocol and vendor. Tumor volume, HPV status, and two radiomics covariates were selected for the CT model, resulting in an AUC of 0.72. However, volume alone produced a higher AUC, whereas adding radiomics features reduced the AUC. HPV status and one radiomics feature were selected as covariates for the PET model, resulting in an AUC of 0.59, but neither covariate was significantly associated with survival. Limiting the training and independent testing to patients with the same imaging protocol reduced the AUC for CT patients to 0.55, and no covariates were selected for PET patients. Radiomics features were not consistently associated with survival in CT or PET images of head and neck patients, even within patients with the same imaging protocol.

Indexed as

AdultAgedAged, 80 and overFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedPositron-Emission TomographyProportional Hazards ModelsRetrospective StudiesTomography, X-Ray ComputedYoung Adult

Identifiers

PMID31536526
PMCPMC6752873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.